ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676315 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676315; 2) Community: the network communities that were significantly associated with the response to NSC 676315; 3) Molecule: the relationships between components within communities and NSC 676315; 4) MDR: the compounds that were significantly associated with the NSC 676315.

NSC Compound Enrichment Correlation
NSC 662123 Null 0.000395532514722381 0.42233148
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.000395532514722381 0.40915566
NSC 681639 Camptothecin Derivative 0.000395532514722381 0.24952226
NSC 681646 Camptothecin Derivative 0.000601164336889762 0.2427309
NSC 748712 Null 0.000601164336889762 0.44534818
NSC 113452 Null 0.00070132188671658 0.25058667
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.00070132188671658 0.33947002
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.000880521445136051 0.23463815
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.000880521445136057 0.31723789
NSC 610457 Camptothecin Derivative 0.000880521445136057 0.23330778
Total:72  Current:3    [First] [Prev] [Next] [Last]